The Ronald D. Mann Best Paper Award
Pharmacoepidemiology and Drug Safety presents The Ronald D. Mann Best Paper Award each year to the first author of the strongest contribution within a given volume, as determined by the Editors and a representative of the International Society for Pharmacoepidemiology (ISPE).
The Award is open to all authors. Certificates and prizes are awarded at ISPE's annual meeting. The award is named for the Founding Editor of the journal, and provided by the publisher, John Wiley & Sons Limited.
2014 (Volume 23)
Jürgen Prestel, Peter Volkers, Dirk Mentzer, Helmar C. Lehmann, Hans-Peter Hartung, and Brigitte Keller-Stanislawski, for the GBS Study Group.
Risk of Guillain–Barré syndrome following pandemic influenza A(H1N1) 2009 vaccination in Germany.
Yuelian Sun, Chun Sen Wu and Jørn Olsen.
Trimethoprim use before pregnancy and risk of congenital malformation: reanalyzed using a case-crossover design and a case-time-control design.
Marsha A. Raebel, Sophia R. Newcomer, Elizabeth A. Bayliss, Denise Boudreau, Lynn DeBar, Thomas E. Elliott, Ameena T. Ahmed, Pamala A. Pawloski, David Fisher, Sengwee Toh and William Troy Donahoo
Chronic opioid use emerging after bariatric surgery.
Douglas C. McDonald and Kenneth E. Carlson.
The ecology of prescription opioid abuse in the USA: geographic variation in patients' use of multiple prescribers (“doctor shopping”).
2013 (Volume 22)
Adriana M. Hung, Christianne L. Roumie, Robert A. Greevy, Xulei Liu, Carlos G. Grijalva, Harvey J. Murff and Marie R. Griffin
Kidney function decline in metformin versus sulfonylurea initiators: assessment of time-dependent contribution of weight, blood pressure, and glycemic control
Shahed Iqbal, John P. Barile, William W. Thompson and Frank DeStefano
Number of antigens in early childhood vaccines and neuropsychological outcomes at age 7–10 years
Carlos Iribarren, Alfred D. Round, Jonathan A. Peng, Meng Lu, Jonathan G. Zaroff, Taylor J. Holve, Amit Prasad and Paul Stang
Validation of a population-based method to assess drug-induced alterations in the QT interval: a self-controlled crossover study
Sylvie D. Price, C. D'Arcy J. Holman, Frank M. Sanfilippo and Jon D. Emery
Use of case–time–control design in pharmacovigilance applications: exploration with high-risk medications and unplanned hospital admissions in the Western Australian elderly
2011 (Volume 20) Finalists
John Paul Leombruno, Geoffrey C Nguyen, Paul Grootendorst, David Juurlink and Tom Einarson. Hospitalization and surgical rates in patients with Crohn's disease treated with infliximab: a matched analysis
(p 838 - 848) Vol 20 Issue 8
Daren Lin, Jamie A Seabrook, Doreen M Matsui, Susan M King, Michael J Rieder, Yaron Finkelstein. Palatability, adherence and prescribing patterns of antiretroviral drugs for children with human immunodeficiency virus infection in Canada
(p 1246 - 1252) Vol 20, Issue 12
Robert L Davis, David Eastman, Heather McPhillips, Marsha A Raebel, Susan E Andrade, David Smith, Marianne Ulcickas Yood, Sascha Dublin and Richard Platt. Risks of congenital malformations and perinatal events among infants exposed to calcium channel and beta-blockers during pregnancy.
(p 138 - 145) Vol 20, Issue 2.
Henriette Thisted Horsdal, Flemming Søndergaard, Søren Paaske Johnsen, Jørgen Rungby. Antidiabetic treatments and risk of hospitalisation with Myocardial infarction: a nationwide case-control study.
(p 331-337) Vol 20, Issue 4.
2010 (Volume 19)
Wendy Klein-Schwartz, John David Sorkin and Suzanne Doyon. Impact of the voluntary withdrawal of over-the-counter cough and cold medications on pediatric ingestions reported to poison centers.
(p 819-824) Vol 19 Issue 8
Laurent Azoulay, Verena Schneider-Lindner, Sophie Dell'Aniello, Alicia Schiffrin and Samy Suissa. Combination therapy with sulfonylureas and metformin and the prevention of death in type 2 diabetes: a nested case-control study.
(p 335-342) Vol 19 Issue 4
Alain Weill, Michel Païta, Philippe Tuppin, Jean-Paul Fagot, Anke Neumann, Dominique Simon, Philippe Ricordeau, Jean-Louis Montastruc and Hubert Allemand. Benfluorex and valvular heart disease: a cohort study of a million people with diabetes mellitus.
(p 1256-1262) Vol 19 Issue 12
Eric S Johnson, Jessica R Weinstein, Micah L Thorp, Robert W Platt, Amanda F Petrik, Xiuhai Yang, Sharon Anderson and David H Smith. Predicting the risk of hyperkalemia in patients with chronic kidney disease starting lisinopril.
(p 266-272) Vol 19 Issue 3
2009 (Volume 18)
Traditional versus marginal structural models to estimate the effectiveness of β-blocker use on mortality after myocardial infarction
Volume 18, Issue 1, January 2009, Pages: 1-6
Abstract | References | Full Text: PDF (Size: 79K)
CommendedEmergency department visits attributed to selected analgesics, United States, 2004–2005
Volume 18, Issue 3, March 2009, Pages: 188-195
CommendedHemorrhagic stroke associated with antidepressant use in patients with depression: does degree of serotonin reuptake inhibition matter?
Volume 18, Issue 3, Marchl 2009, Pages: 196-202
2008 (Volume 17)
Lung cancer and regular use of aspirin and nonaspirin nonsteroidal anti-inflammatory drugs
Volume 17, Issue 4, April 2008, Pages: 322-327
Abstract | References | Full Text: PDF (Size: 74K)
CommendedModerate and high affinity serotonin reuptake inhibitors increase the risk of upper gastrointestinal toxicity
Volume 17, Issue 4, April 2008, Pages: 328-335
Onset of acute myocardial infarction after use of non-steroidal anti-inflammatory drugs
Volume 17, Issue 4, April 2008, Pages: 315-321
2007 (Volume 16)
Early detection of adverse drug events within population-based health networks: application of sequential testing methods
Volume 16, Issue 12, December 2007, Pages: 1275-1284
The impact of over-the-counter simvastatin on the number of statin prescriptions in the United Kingdom: a view from the General Practice Research Database
Volume 16, Issue 1, January 2007, Pages: 1-4
Abstract | References | Full Text: PDF (Size:87K)
CommendedRisk of local adverse events by gender following cardiac catheterization
Volume 16, Issue 2, Date: February 2007, Pages: 125-131
2006 (Volume 15)
FDA drug prescribing warnings: is the black box half empty or half full?
Volume 15, Issue 6, June 2006, Pages: 369-386
Cardiovascular risk of selective cyclooxygenase-2 inhibitors and other non-aspirin non-steroidal anti-inflammatory medications
Volume 15, Issue 9, September 2006, Pages: 641-652
2005 (Volume 14)
Impact of regulatory labeling for troglitazone and rosiglitazone on hepatic enzyme monitoring compliance: findings from the state of Ohio medicaid program
Volume 14, Issue 1, January 2005, Pages: 1-9
Benzodiazepines and injury: a risk adjusted model
Volume 14, Issue 1, Date: January 2005, Pages: 17-24
Selective prescribing of atypical antipsychotics
Volume 14, Issue 1, Date: January 2005, Pages: 25-30
Abstract | References | Full Text: HTML , PDF (Size: 67K)
Generating signals of drug-adverse effects from prescription databases and application to the risk of arrhythmia associated with antibacterials
Volume 14, Issue 1, Date: January 2005, Pages: 31-40
Small proportions: what to report for confidence intervals?
Volume 15, Issue 3, Date: March 2006, Pages: 211
Abstract | References | Full Text: PDF (Size: 202K)
2004 (Volume 13)
Application of a propensity score to adjust for channelling bias with NSAIDs
Volume 13, Issue 6, June 2004, Pages: 345-353
High frequency of use of rofecoxib at greater than recommended doses: cause for concern
Volume 13, Issue 6, June 2004, Pages: 339-343
Use of inhaled corticosteroids and bone mineral density in a population based study: the Nord-Trøndelag Health Study (the HUNT Study)
Volume 13, Issue 8, Date: August 2004, Pages: 569-579
Infant vaccinations and childhood asthma among full-term infants
Volume 13, Issue 1, Date: January 2004, Pages: 1-9
2003 (Volume 12)
The risk of liver disorders in women prescribed cyproterone acetate in combination with ethinyloestradiol (Dianette): a nested case-control study using the GPRD
Volume 12, Issue 7, October/November 2003, Pages: 541-550
Increased suicide attempt rate among patients interrupting use of atypical antipsychotics
Volume 12, Issue 5, July/August 2003, Pages: 423-424
Liver function testing in patients on HMG-CoA reductase inhibitors
Volume 12, Issue 4, Date: June 2003, Pages: 307-313
A case-control study of acetaminophen use in relation to the risk of first myocardial infarction in men
Volume 12, Issue 6, Date: September 2003, Pages: 459-465
Adverse pregnancy outcomes associated with maternal enalapril antihypertensive treatment
Volume 12, Issue 8, Date: December 2003, Pages: 633-646
Abstract | References | Full Text: HTML , PDF (Size: 120K)
2002 (Volume 11)
Wheezing lower respiratory disease and vaccination of full-term infants
Volume 11, Issue 1, January/February 2002, Pages: 21-30
Estrogen replacement therapy and risk of lung cancer
Volume 11, Issue 7, Date: Oct-Nov 2003, Pages: 561-7
Abstract | References | Full Text: HTML , PDF (Size: 72K)
Postmarketing drug dosage changes of 499 FDA-approved new molecular entities, 1980-1999
Volume 11, Issue 6, Date: September 2002, Pages: 439-446
Abstract | References | Full Text: HTML , PDF (Size: 88K)
Changes in prescribed drug doses after market introduction
Volume 11, Issue 6, Date: September 2002, Pages: 447-453
Abstract | References | Full Text: HTML , PDF (Size: 80K)
Parenteral ketorolac and risk of myocardial infarction
Volume 11, Issue 2, Date: March 2002, Pages: 113-119
Abstract | References | Full Text: HTML , PDF (Size: 76K)
2001 (Volume 10)
Antihypertensives and myocardial infarction risk: the modifying effect of history of drug use
Volume 10, Issue 4, June/July 2001, Pages: 287-294